title: Pregabalin for neuropathic pain based on recent clinical trials.
abstract: Pregabalin is a ligand for the alpha-2-delta subunit of voltage-gated calcium channels with anticonvulsant, analgesic, and anxiolytic properties. It has predictable absorption across the gastrointestinal tract, is neither metabolized nor protein-bound, and has minimal drug-drug interactions. It is effective with two or three-times daily dosing in a dose range of 150 to 600 mg daily. Seven published prospective, randomized clinical trials in postherpetic neuralgia (PHN) and painful diabetic peripheral neuropathy (DPN) demonstrate pain relief, decreased sleep interference, and improvements in several secondary outcome measures. The 50% responder rates for PHN and DPN compare favorably with other first-line agents for neuropathic pain. Pregabalin is well tolerated in most patients with infrequent severe adverse effects. Pregabalin is an important addition to the treatment armamentarium for neuropathic pain.
authors.affiliation: Department of Anesthesiology & Peri-Operative Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mailcode OP-26, Portland, OR 97239, USA. staceyb@ohsu.edu
authors.forename: Brett R
authors.initials: BR
authors.lastname: Stacey
authors.forename: Jon N
authors.initials: JN
authors.lastname: Swift
mesh_terms: D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009437:Neuralgia / Q000188:drug therapy*; D000069583:Pregabalin; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000700:Analgesics; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid
references.citation: J Clin Psychopharmacol. 2004 Apr;24(2):141-9
references.pmid: 15206660
references.citation: Ann Neurol. 2005 Aug;58(2):309-12
references.pmid: 15991228
references.citation: Arch Gen Psychiatry. 2005 Sep;62(9):1022-30
references.pmid: 16143734
references.citation: Med Lett Drugs Ther. 2005 Sep 12;47(1217):75-6, 73
references.pmid: 16151369
references.citation: Epilepsy Res. 1998 Jul;31(2):91-9
references.pmid: 9714500
references.citation: Neurobiol Dis. 1998 Oct;5(4):209-27
references.pmid: 9848092
references.citation: PLoS Med. 2005 Jul;2(7):e164
references.pmid: 16013891
references.citation: J Clin Psychopharmacol. 2003 Jun;23(3):240-9
references.pmid: 12826986
references.citation: Epilepsy Res. 2000 Jul;40(2-3):123-7
references.pmid: 10863139
references.citation: Drugs. 2005;65(1):111-8; discussion 119-20
references.pmid: 15610058
references.citation: Curr Opin Pharmacol. 2006 Feb;6(1):108-13
references.pmid: 16376147
references.citation: J Pain Symptom Manage. 2005 Oct;30(4):374-85
references.pmid: 16256902
references.citation: Pain. 2005 Dec 5;118(3):289-305
references.pmid: 16213659
references.citation: Pain. 2005 Jun;115(3):254-263
references.pmid: 15911152
references.citation: Drugs. 2004;64(24):2813-20; discussion 2821
references.pmid: 15563250
references.citation: Am J Psychiatry. 2003 Mar;160(3):533-40
references.pmid: 12611835
references.citation: J Clin Endocrinol Metab. 2005 Aug;90(8):4936-45
references.pmid: 15899953
references.citation: Pain. 2004 May;109(1-2):26-35
references.pmid: 15082123
references.citation: Neurology. 2003 Apr 22;60(8):1274-83
references.pmid: 12707429
references.citation: Reg Anesth Pain Med. 1999 Jan-Feb;24(1):5-7
references.pmid: 9952087
references.citation: Acta Neurol Scand. 2004 Dec;110(6):368-76
references.pmid: 15527449
references.citation: J Pain. 2005 Apr;6(4):253-60
references.pmid: 15820913
references.citation: Curr Med Res Opin. 2006 Feb;22(2):375-84
references.pmid: 16466610
references.citation: Neurology. 2004 Sep 28;63(6):959-65
references.pmid: 15452284
references.citation: Evid Based Ment Health. 2004 Feb;7(1):17
references.pmid: 14769661
references.citation: Ann Pharmacother. 2005 Dec;39(12):2029-37
references.pmid: 16288079
references.citation: Pain. 2005 Mar;114(1-2):29-36
references.pmid: 15733628
references.citation: Clin J Pain. 2006 Jan;22(1 Suppl):S2-8
references.pmid: 16344609
references.citation: Am J Phys Med Rehabil. 2005 Mar;84(3 Suppl):S4-16
references.pmid: 15722782
references.citation: J Pharmacol Exp Ther. 2005 Jun;313(3):1406-15
references.pmid: 15769862
references.citation: Pharm Res. 2001 Aug;18(8):1126-30
references.pmid: 11587483
references.citation: Epilepsia. 2004;45 Suppl 6:13-8
references.pmid: 15315511
references.citation: Prescrire Int. 2005 Dec;14(80):203-6
references.pmid: 16397976
references.citation: Pain. 2001 Nov;94(2):149-158
references.pmid: 11690728
references.citation: Epilepsia. 2005 Sep;46(9):1407-13
references.pmid: 16146435
references.citation: Sleep. 2005 Feb;28(2):187-93
references.pmid: 16171242
references.citation: Arthritis Rheum. 2005 Apr;52(4):1264-73
references.pmid: 15818684
references.citation: Pain. 2004 Aug;110(3):628-638
references.pmid: 15288403
references.citation: J Clin Psychopharmacol. 2005 Apr;25(2):151-8
references.pmid: 15738746
references.citation: Fed Regist. 2005 Jul 28;70(144):43633-5
references.pmid: 16050051
references.citation: Neurology. 2004 Dec 14;63(11):2104-10
references.pmid: 15596757
references.citation: Neurology. 2005 Dec 29;65(12 Suppl 4):S66-73
references.pmid: 16385106